Newsroom
Recent Announcements
PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.”
Featured Article
“Breaking Through the FDA” (Biosphere, 2021)
Innovative medical devices and diagnostics can get to patients and providers sooner under the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Program. The program provides a special regulatory Breakthrough Device Designation for medical products that have the potential to more effectively treat or diagnose serious or life-threatening conditions. See the full article on page 19 >
We're getting lots of questions about our upcoming phase 3 trial. We wish we could share some answers!
The best thing you can do to stay informed about our trial, including news and recruitment, is make sure you're signed up to receive our emails: http://PhotoPharmics.com/connect
Some people actually feel relieved when they get a Parkinson's disease diagnosis, because it's an explanation for how they feel on the inside and out.
See more resources for the newly diagnosed on @ParkinsonDotOrg: https://www.parkinson.org/newlydiagnosed
9 hours ago ·
1 day ago ·
2 days ago ·
Archived Content